Study S001787

Treatment With Tirzepatide of the Disease of Obesity in People With Type 1 Diabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07096908
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: QUADRUPLE
Status: RECRUITING
Enrollment: 60
Start: 2025-07-31
Primary completion: 2028-02-25
Lead sponsor: Dasman Diabetes Institute
Conditions: Type1diabetes; Obesity
Interventions: DRUG:Tirzepatide; DRUG:Placebo
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Bodyweight [76 weeks]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0013810	Treatment of the disease of obesity in patients with type 1 diabetes with tirzepatide: a protocol for a randomised controlled trial in a single-centre setting. Al Ozairi E, BMJ open	2026	Protocol	PMID 42097660 DOI	cites ClinicalTrials.gov:NCT07096908; registry reference DERIVED:42097660